File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation

TitleAnimal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
Authors
Issue Date2022
Citation
World Journal of Virology, 2022, v. 11, p. 40-56 How to Cite?
AbstractThere is a critical need to develop animal models to alleviate vaccine and drug development difficulties against zoonotic viral infections. The coronavirus family, which includes severe acute respiratory syndrome coronavirus 1 and severe acute respiratory syndrome coronavirus 2, crossed the species barrier and infected humans, causing a global outbreak in the 21st century. Because humans do not have pre-existing immunity against these viral infections and with ethics governing clinical trials, animal models are therefore being used in clinical studies to facilitate drug discovery and testing efficacy of vaccines. The ideal animal models should reflect the viral replication, clinical signs, and pathological responses observed in humans. Different animal species should be tested to establish an appropriate animal model to study the disease pathology, transmission and evaluation of novel vaccine and drug candidates to treat coronavirus disease 2019. In this context, the present review summarizes the recent progress in developing animal models for these two pathogenic viruses and highlights the utility of these models in studying SARS-associated coronavirus diseases.
Persistent Identifierhttp://hdl.handle.net/10722/318115

 

DC FieldValueLanguage
dc.contributor.authorSaravanan, UB-
dc.contributor.authorNamachivayam, M-
dc.contributor.authorJeewon, R-
dc.contributor.authorHuang, J-
dc.contributor.authorDurairajan, SSK-
dc.date.accessioned2022-10-07T10:32:57Z-
dc.date.available2022-10-07T10:32:57Z-
dc.date.issued2022-
dc.identifier.citationWorld Journal of Virology, 2022, v. 11, p. 40-56-
dc.identifier.urihttp://hdl.handle.net/10722/318115-
dc.description.abstractThere is a critical need to develop animal models to alleviate vaccine and drug development difficulties against zoonotic viral infections. The coronavirus family, which includes severe acute respiratory syndrome coronavirus 1 and severe acute respiratory syndrome coronavirus 2, crossed the species barrier and infected humans, causing a global outbreak in the 21st century. Because humans do not have pre-existing immunity against these viral infections and with ethics governing clinical trials, animal models are therefore being used in clinical studies to facilitate drug discovery and testing efficacy of vaccines. The ideal animal models should reflect the viral replication, clinical signs, and pathological responses observed in humans. Different animal species should be tested to establish an appropriate animal model to study the disease pathology, transmission and evaluation of novel vaccine and drug candidates to treat coronavirus disease 2019. In this context, the present review summarizes the recent progress in developing animal models for these two pathogenic viruses and highlights the utility of these models in studying SARS-associated coronavirus diseases.-
dc.languageeng-
dc.relation.ispartofWorld Journal of Virology-
dc.titleAnimal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation-
dc.typeArticle-
dc.identifier.emailHuang, J: jdhuang@hku.hk-
dc.identifier.authorityHuang, J=rp00451-
dc.identifier.doi10.5501/wjv.v11.i1.40-
dc.identifier.hkuros337882-
dc.identifier.volume11-
dc.identifier.spage40-
dc.identifier.epage56-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats